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The publisher regrets that there was an error in the ‘Exacerbations’ section of the above paper.
The text should have read:
Hazard ratios of time-to-first exacerbation showed no significant effect of any active treatment on risk of exacerbation
compared with placebo: indacaterol 150 mg, 0.73 (95% CI 0.03e1.78); indacaterol 300 mg, 0.82 (95% CI 0.36e1.91); open-
label tiotropium, 0.71 (95% CI 0.22e2.31).
The publisher would like to apologise for any inconvenience caused.DOI of original article: http://dx.doi.org/10.1016/j.rmed.2012.
08.022.
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